MIV Therapeutics, Inc.

MIV Therapeutics announces availability of updated investor fact sheet

Published in Pharma Law Weekly, April 25th, 2006

MIV Therapeutics, Inc. (MIVT, MIV) announced the availability of an updated investor fact sheet that outlines the company's proprietary and novel technologies, and its research programs to develop improved coatings for drug-eluting vascular stents and other implantable medical devices.

MIVT is also developing a novel stroke-prevention device through its wholly owned subsidiary, SagaX Inc., located in Herzlyia, Israel. SagaX is a developer of advanced biomedical technology, including the aortic embolic protection device (AEPD). The AEPD is a unique and proprietary filter/deflector device designed specifically to prevent cardioembolic stroke following heart surgery. SagaX...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2006-04-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry